(Q28577251)

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Doxorubicin-induced persistent oxidative stress to cardiac myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Adriamycin-induced oxidative mitochondrial cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Cardiotoxicity of anticancer treatments: what the cardiologist needs to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Modulation of anthracycline-induced cardiotoxicity by aerobic exercise in breast cancer: current evidence and underlying mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

CREB-binding protein and p300 in transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

p300 and CBP: partners for life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

CBP and p300: HATs for different occasions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

The p300/CBP family: integrating signals with transcription factors and chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Phosphorylation-dependent degradation of p300 by doxorubicin-activated p38 mitogen-activated protein kinase in cardiac cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Proteasome-mediated degradation of the coactivator p300 impairs cardiac transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Life and death of transcriptional co-activator p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Calcium-dependent enhancement of transcription of p300 by human T-lymphotropic type 1 p12I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Expression of p300 protects cardiac myocytes from apoptosis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

The role of STATs in transcriptional control and their impact on cellular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Angiotensinogen gene expression is dependent on signal transducer and activator of transcription 3-mediated p300/cAMP response element binding protein-binding protein coactivator recruitment and histone acetyltransferase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Reactive oxygen species regulate heat-shock protein 70 via the JAK/STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

The EGFR-STAT3 oncogenic pathway up-regulates the Eme1 endonuclease to reduce DNA damage after topoisomerase I inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Stat3 activation of NF-{kappa}B p100 processing involves CBP/p300-mediated acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Requirement of histone deacetylase1 (HDAC1) in signal transducer and activator of transcription 3 (STAT3) nucleocytoplasmic distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Stat3 dimerization regulated by reversible acetylation of a single lysine residue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Stat protein transactivation domains recruit p300/CBP through widely divergent sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Adrenergic regulation of the skeletal alpha-actin gene promoter during myocardial cell hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Priming of signal transducer and activator of transcription proteins for cytokine-triggered polyubiquitylation and degradation by the A 2A adenosine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Control of Smad7 stability by competition between acetylation and ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Bone morphogenetic protein-2 stimulates Runx2 acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Site-specific acetylation of the fetal globin activator NF-E4 prevents its ubiquitination and regulates its interaction with the histone deacetylase, HDAC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Regulation of the p300 HAT domain via a novel activation loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Trichostatin A enhances acetylation as well as protein stability of ERalpha through induction of p300 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Histone acetyl transferases as emerging drug targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Deacetylase recruitment by the C/H3 domain of the acetyltransferase p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Histone modifying enzymes: structures, mechanisms, and specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Structure and function of histone acetyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Kinetic and mass spectrometric analysis of p300 histone acetyltransferase domain autoacetylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

The SIRT2 deacetylase regulates autoacetylation of p300

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

The type III histone deacetylase Sirt1 protein suppresses p300-mediated histone H3 lysine 56 acetylation at Bclaf1 promoter to inhibit T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Regulation of E2F-1 after DNA damage by p300-mediated acetylation and ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Polyubiquitination of p53 by a ubiquitin ligase activity of p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

HIV-1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Myocardial regulation of p300 and p53 by doxorubicin involves ubiquitin pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Reactive oxygen species in mechanical stress-induced cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Histone deacetylase inhibitors: anticancer compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Clinical studies of histone deacetylase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Histone deacetylase interacts directly with DNA topoisomerase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

HDAC2 regulates chromatin plasticity and enhances DNA vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Anthracycline-associated cardiotoxicity in survivors of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6

Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2069-6